 |  |
| ABX | ||
| 2,933.162 | ||
| 63.5060 | 0.0221% | |
| BISNIS-27 | ||
| 436.836 | ||
| 0.5710 | 0.0013% | |
| DBX | ||
| 2,893.830 | ||
| -42.0080 | -0.0143% | |
| ECONOMIC30 | ||
| 87.442 | ||
| -0.0480 | -0.0005% | |
| ESGQKEHATI | ||
| 103.236 | ||
| -0.1440 | -0.0014% | |
| ESGSKEHATI | ||
| 104.326 | ||
| -0.1070 | -0.0010% | |
| I-GRADE | ||
| 157.522 | ||
| -0.5300 | -0.0034% | |
| AUDRP | ||
| 12,531.170 | ||
| 19.7500 | 0.1579% | |
| EURRP | ||
| 20,594.310 | ||
| 39.3300 | 0.1913% | |
| JPYRP | ||
| 110.721 | ||
| 0.3749 | 0.3397% | |
| SINRP | ||
| 13,837.150 | ||
| 30.7100 | 0.2224% | |
| USDRP | ||
| 17,742.000 | ||
| 38.0000 | 0.2146% | |
Pandemi COVID-19 mendorong Indonesia untuk memproduksi obat-obatan dan alat kesehatan (alkes) secara mandiri. Pemerintah mengupayakan ketergantungan terhadap produk impor berkurang hingga 35 persen pada akhir 2022.
